The goal for the Tissue Engineering Platform is to provide the CRG, PRBB and external researchers with the latests technologies used in the fields of stem cell biology, stem cell differentiation, organoid formation and induced pluripotent stem cells (iPSCs) . The Unit is constantly setting up new technologies that are emerging in the above fields.
The Tissue Engineering platform works in collaboration with the Biomolecular Screening & Protein Technologies Unit at the CRG to provide CRISPR/Cas9 genome editing technology service.
- Mouse ES cell derivation
- Human iPS cell projects
- Stem cell differentiation
- CRISPR/CAS9 Gene Editing Technology
- Embryo Micromanipulation